- ►v2020la.org [PDF] H Kuper, R Wormald - British Journal of Ophthalmology, 2007 - bjo.bmj.com Azithromycin is costly, but, thanks to Pfizer's generous donation of the drug,
mass distribution has been undertaken in 11 countries in Africa and Asia.
Because oral azithromycin can be used to treat other diseases, there is a ... Cited by 1 - Related articles - BL Direct - All 5 versions
I Cochereau, P Goldschmidt, A Goepogui, T … - British Medical Journal, 2007 - bjo.bmj.com Methods: Randomised, controlled, double-masked, double-dummy, non-inferiority
explanatory study including 670 children from Guinea Conakry and Pakistan if:
1–10 years old; active trachoma (TF+TI0 or TF+TI+ on simplified World ... Cited by 4 - Related articles - BL Direct - All 5 versions
HR Wright, JE Keeffe, HR Taylor - British Journal of Ophthalmology, 2006 - bjo.bmj.com The past decade has seen a major reduction in the burden of infectious
blindness, of which trachoma is the leading cause. Repeated infection with the
obligate intracellular bacteria Chlamydia trachomatis results in the ... Cited by 6 - Related articles - BL Direct - All 5 versions
G Nagpal, U Dhaliwal, MS Bhatia - Ophthalmic epidemiology, 2006 - informahealthcare.com Purpose: To determine the barriers to therapeutic intervention in patients with
trachomatous trichiasis or entropion. Methods: Prospective study over one year
in 60 patients with trachomatous trichiasis or entropion presenting to a ... Cited by 4 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org P Cumberland, T Edwards, G Hailu, E … - International Journal of Epidemiology, 2008 - IEA Background The International Trachoma Initiative (ITI) trachoma control
programme based on the SAFE strategy (Surgery, Antibiotics, Facial cleanliness
and Environmental improvement) was implemented in 2002 in two rural ... Cited by 4 - Related articles - All 5 versions
[CITATION] Pharmacokinetics of azithromycin in active trachoma patients
JI House, B Ayele, TC Porco, Z Zhou, KC … - The Lancet, 2009 - Elsevier In a cluster randomised trial, 24 subkebeles (government-defined units) in
Amhara, Ethiopia, were randomised, with use of a simple random sample, to
distribution four times per year of single-dose oral azithromycin to ... Cited by 4 - Related articles - All 17 versions
T Lietman, A Fry - British Journal of Ophthalmology, 2001 - bjo.bmj.com Trachoma is the leading cause of preventable blindness worldwide.1 Although it
disappeared long ago from Western Europe and the United States, trachoma is
still as endemic as ever in parts of Africa, the Middle East, Australia, ... Cited by 5 - Related articles - BL Direct - All 7 versions
CR Dawson, T Daghfous, J Whitcher, M … - Bulletin of the World Health Organization, 1981 - pubmedcentral.nih.gov In communities with endemic blinding trachoma, mass (or ”blanket”) treatment
with a topically applied tetracycline derivative is a standard control measure.
The widely used ”intermittent” treatment schedule consists of the twice ... Cited by 6 - Related articles - All 7 versions
A Abdou, B Nassirou, B Kadri, F Moussa, BE … - British Medical Journal, 2007 - bjo.bmj.com Results: The prevalence of trachoma was 43% (95% confidence interval (CI) 39% to
47%) and of infection was 21% (95% CI 18% to 24%). Children aged 3–5 years had
a stronger association of clinical signs with infection, compared with ... Cited by 6 - Related articles - BL Direct - All 5 versions
